These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38700008)

  • 21. CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial.
    Gibson CM; Kazmi SHA; Korjian S; Chi G; Phillips AT; Montazerin SM; Duffy D; Zheng B; Heise M; Liss C; Deckelbaum LI; Wright SD; Gille A
    J Cardiovasc Pharmacol Ther; 2022; 27():10742484221121507. PubMed ID: 36282079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil-to-Lymphocyte Ratio at Emergency Room Predicts Mechanical Complications of ST-segment Elevation Myocardial Infarction.
    Yoon GS; Choi SH; Woo SI; Baek YS; Park SD; Shin SH; Kim DH; Kwan J; Lee MJ; Kwon SW
    J Korean Med Sci; 2021 May; 36(19):e131. PubMed ID: 34002551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between neutrophil/lymphocyte ratio and infarct-related artery patency before mechanical reperfusion in patients with ST-elevation myocardial infarction.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Ocek AH
    Coron Artery Dis; 2014 Mar; 25(2):159-66. PubMed ID: 24326783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel predictors of infarct-related artery patency for ST-segment elevation myocardial infarction: Platelet-to-lymphocyte ratio, uric acid, and neutrophil-to-lymphocyte ratio.
    Acet H; Ertaş F; Akıl MA; Özyurtlu F; Yıldız A; Polat N; Bilik MZ; Aydın M; Oylumlu M; Kaya H; Yüksel M; Akyüz A; Ayçiçek H; Alan S; Toprak N
    Anatol J Cardiol; 2015 Aug; 15(8):648-56. PubMed ID: 25550174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction.
    Sawant AC; Adhikari P; Narra SR; Srivatsa SS; Mills PK; Srivatsa SS
    Cardiol J; 2014; 21(5):500-8. PubMed ID: 24142685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Admission Neutrophil to Lymphocyte Ratio Predict Infarct-Related Artery Patency in ST-Segment Elevation Myocardial Infarction.
    Doğan M; Akyel A; Bilgin M; Erat M; Çimen T; Sunman H; Efe TH; Açıkel S; Yeter E
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):172-6. PubMed ID: 24322278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA.
    Paolisso P; Foà A; Bergamaschi L; Donati F; Fabrizio M; Chiti C; Angeli F; Toniolo S; Stefanizzi A; Armillotta M; Rucci P; Iannopollo G; Casella G; Marrozzini C; Galiè N; Pizzi C
    Cardiovasc Diabetol; 2021 Feb; 20(1):33. PubMed ID: 33530978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship Between Prodromal Angina Pectoris and Neutrophil-to Lymphocyte Ratio in Patients With ST Elevation Myocardial Infarction.
    Gok M; Kundi H; Kiziltunc E; Evlice M; Cetin M; Suleymanoglu M; Kurtul A; Ornek E
    Heart Lung Circ; 2019 Jun; 28(6):901-907. PubMed ID: 29735396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
    Michael Gibson C; Korjian S; Tricoci P; Daaboul Y; Yee M; Jain P; Alexander JH; Steg PG; Lincoff AM; Kastelein JJ; Mehran R; D'Andrea DM; Deckelbaum LI; Merkely B; Zarebinski M; Ophuis TO; Harrington RA
    Circulation; 2016 Dec; 134(24):1918-1930. PubMed ID: 27881559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with thrombolysis in myocardial infarction frame count in ST-segment elevation myocardial infarction.
    Vakili H; Shirazi M; Charkhkar M; Khaheshi I; Memaryan M; Naderian M
    Eur J Clin Invest; 2017 Apr; 47(4):322-327. PubMed ID: 28177528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of neutrophil-to-lymphocyte ratio with GRACE risk score to in-hospital cardiac events in patients with ST-segment elevated myocardial infarction.
    Oncel RC; Ucar M; Karakas MS; Akdemir B; Yanikoglu A; Gulcan AR; Altekin RE; Demir I
    Clin Appl Thromb Hemost; 2015 May; 21(4):383-8. PubMed ID: 24078555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil to Lymphocyte Ratio is Related to Stent Thrombosis and High Mortality in Patients With Acute Myocardial Infarction.
    Ayça B; Akın F; Celik O; Sahin I; Yildiz SS; Avci II; Gulsen K; Okuyan E; Dinckal MH
    Angiology; 2015 Jul; 66(6):545-52. PubMed ID: 25024461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarction.
    Capodanno D; Mehran R; Gibson CM; Angiolillo DJ
    Expert Opin Investig Drugs; 2018 Dec; 27(12):997-1005. PubMed ID: 30376729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On-admission High Neutrophil to Lymphocyte Ratio as Predictor of In-hospital Adverse Cardiac Event in ST-elevation Myocardial Infarction.
    Hartopo AB; Puspitawati I; Setianto BY
    Acta Med Indones; 2015 Jan; 47(1):3-10. PubMed ID: 25948761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet to Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Sun XP; Li J; Zhu WW; Li DB; Chen H; Li HW; Chen WM; Hua Q
    Angiology; 2018 Jan; 69(1):71-78. PubMed ID: 28464698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long-term predictive value of the neutrophil-to-lymphocyte ratio in Type 2 diabetic patients presenting with acute myocardial infarction.
    Lee GK; Lee LC; Chong E; Lee CH; Teo SG; Chia BL; Poh KK
    QJM; 2012 Nov; 105(11):1075-82. PubMed ID: 22771557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients.
    Zheng B; Duffy D; Tricoci P; Kastrissios H; Pfister M; Wright SD; Gille A; Tortorici MA
    Br J Clin Pharmacol; 2021 Jun; 87(6):2558-2571. PubMed ID: 33217027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
    Gille A; D'Andrea D; Tortorici MA; Hartel G; Wright SD
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):953-963. PubMed ID: 29437574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience.
    Zuin M; Rigatelli G; Picariello C; dell'Avvocata F; Marcantoni L; Pastore G; Carraro M; Nanjundappa A; Faggian G; Roncon L
    Cardiovasc Revasc Med; 2017 Dec; 18(8):565-571. PubMed ID: 28529092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.
    Zhang S; Diao J; Qi C; Jin J; Li L; Gao X; Gong L; Wu W
    BMC Cardiovasc Disord; 2018 May; 18(1):75. PubMed ID: 29716535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.